26 Aug , 2025 By : Debdeep Gupta
Shares of Sai Life Sciences slipped as much as 4 percent to Rs 871 in morning trade on Tuesday, August 26, after private equity firm TPG Asia offloaded its entire 15.2 percent holding in the Hyderabad-based CRDMO through block deals, CNBC TV-18 reported.
The sale, estimated at nearly Rs 2,810 crore, involves about 3.16 crore shares and carries a floor price of Rs 874 per share, roughly at a 3.5 percent discount from the previous close of Rs 906 per share.
A Source couldn't independently verify the buyers and sellers of the deal. If it is TPG Asia, the move marks a complete exit for the investor at a time when the company has been reporting decent growth across businesses.
In the June quarter of FY26, Sai Life swung to a profit of Rs 60 crore from a Rs 13 crore loss a year ago, while revenue from operations surged 77 percent to Rs 496 crore. The CDMO segment led the charge with a 113 percent jump, while Discovery services grew 38 percent.
Operating performance too strengthened sharply, with EBITDA rising to Rs 125 crore and margins widening to 25 percent from 11 percent a year earlier, aided by scale and productivity gains. Looking ahead, the company has guided for 15–20 percent annual revenue growth over the next three to five years and aims to lift margins to around 30 percent.
At about 9:25 am, shares of the company were trading at Rs 873, lower by 3.8 percent from the last close on the NSE. Sai Life shares have been strong recently, rallying over 25 percent in the last three months.
0 Comment